查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573028

體型雕塑市場：按治療類型、技術、最終用戶、應用、產品類型 - 全球預測 2025-2030

Body Contouring Market by Treatment Type (Invasive, Minimally Invasive, Non-Invasive), Technology (Cryolipolysis, Injectables, Laser), End-User, Application, Product Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年體型雕塑市場價值為3.5437億美元，預計到2024年將達到3.8748億美元，複合年成長率為11.62%，到2030年將達到7.6534億美元。

體型雕塑包括旨在調整人體外觀並使其更加美麗的各種醫療程序。這包括抽脂和腹部除皺術等手術技術，以及酷塑和雷射治療等非手術治療。肥胖率上升、美學意識增強以及非侵入性手術技術進步推動了世界對體型雕塑日益成長的需求。主要應用包括減脂、橘皮組織治療、緊膚和活膚，以滿足診所、醫院和水療中心等客戶的需求。隨著越來越多的人將外表與健康放在一起，體型雕塑市場面臨著巨大的成長機會。主要促進因素包括提高安全性、縮短恢復時間以及提高所有性別和年齡的人對整容手術的接受度。然而，挑戰依然存在。高額手術成本、嚴格的監管合規性以及手術干預的潛在副作用可能會阻礙市場成長。此外，不一致的經濟狀況可能會影響個人在整容手術上的可自由支配支出。儘管有這些障礙，該市場在亞太和拉丁美洲等地區仍有潛力，這些地區的中產階級人口不斷成長，可支配收入不斷增加。公司應該透過擴大服務範圍並投資冷凍溶脂和射頻設備等先進技術來利用這些機會。在技​​術創新方面，市場參與者可以透過專注於客製化治療以及整合人工智慧和機器學習來提高治療效果來實現差異化。尋找無痛、高效且經濟的手術也是一個有前景的領域。體型雕塑市場的本質是動態和競爭的，不斷的創新推動市場的開拓。企業需要跟上消費趨勢，利用數位行銷並建立強大的客戶教育管道，以巧妙地維持和擴大市場佔有率。

主要市場統計
基準年[2023] 3.5437億美元
預測年份 [2024] 38748萬美元
預測年份 [2030] 76534萬美元
複合年成長率（%） 11.62%

市場動態：揭示快速發展的體型雕塑市場的關鍵市場洞察

供需的動態交互作用正在改變體型雕塑市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 不斷擴大的醫療旅遊業推動了對負擔得起的服務的需求
    • 肥胖和相關疾病發生率的增加增加了人們對體型雕塑的興趣
    • 社群媒體和名人代言對促進體型雕塑治療的影響
    • 開發創新的體型雕塑治療方法，最大限度地減少停機時間並加快恢復速度
  • 市場限制因素
    • 潛在患者缺乏對體型雕塑治療的認知與知識
    • 與體型雕塑手術相關的潛在健康風險會影響患者的信心
  • 市場機會
    • 透過提高新興國家體型雕塑普及率開拓市場
    • 主要企業之間的策略聯盟和收購可提高市場佔有率和成長
    • 由於男性對體型雕塑手術的認知和接受度不斷提高，新的細分市場得以創建
  • 市場挑戰
    • 冷凍溶脂、超音波和雷射治療等非侵入性減脂治療的競爭日益激烈，影響市場佔有率
    • 高額治療費用和缺乏保險覆蓋阻礙患者選擇體型雕塑手術

波特五力：駕馭體型雕塑市場的策略工具

波特的五力是了解體型雕塑市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解體型雕塑市場的外在影響

外部宏觀環境因素在體型雕塑市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解體型雕塑市場的競爭格局

對體型雕塑市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣體型雕塑市場廠商績效評估

FPNV定位矩陣是評估體型雕塑市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製體型雕塑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對體型雕塑市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫療旅遊業的擴張增加了對經濟實惠的體型雕塑服務的需求
      • 肥胖及相關疾病發生率的上升增加了人們對體型雕塑的興趣。
      • 社群媒體與名人代言對推廣體型雕塑治療的影響
      • 開發創新的體型雕塑治療方法，最大限度地減少停機時間並確保快速恢復
    • 抑制因素
      • 潛在患者對體型雕塑手術的認知與了解有限
      • 與影響患者信心的體型雕塑手術相關的潛在健康風險
    • 機會
      • 由於採用率不斷上升，新興國家的體型雕塑手術市場不斷擴大
      • 主要企業之間的策略聯盟和收購增加了市場佔有率和成長
      • 提高男性對體型雕塑手術的認知與接受度，創造新的市場
    • 任務
      • 來自冷凍、超音波療法和雷射療法等非侵入性減脂治療的競爭日益激烈，正在影響市場佔有率。
      • 由於費用高且缺乏保險，患者對選擇體型雕塑手術猶豫不決。
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依治療類型體型雕塑市場

  • 侵入性的
    • 下半身提升
    • 傳統抽脂手術
    • 腹部手術
  • 微創
    • 雷射抽脂手術
    • 射頻抽脂術
  • 非侵入性
    • 冷卻脂分解
    • 高強度聚焦超音波（HIFU）
    • 雷射溶脂
    • 無線電頻率

第7章體型雕塑市場：依技術分類

  • 冷卻脂分解
  • 注射
  • 雷射
  • 無線電頻率
  • 超音波

第8章體型雕塑市場：依最終用戶分類

  • 醫院
  • 醫療水療
  • 專科診所

第9章體型雕塑市場：依應用分類

  • 腹部
  • 武器
  • 身體和背部
  • 臀部
  • 大腿

第10章體型雕塑市場：依產品類型

  • 消耗品
  • 裝置

第11章 美洲體型雕塑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太體型雕塑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲體型雕塑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0455

The Body Contouring Market was valued at USD 354.37 million in 2023, expected to reach USD 387.48 million in 2024, and is projected to grow at a CAGR of 11.62%, to USD 765.34 million by 2030.

Body contouring encompasses a range of medical procedures aimed at reshaping and enhancing the human body's appearance. It involves both surgical techniques, such as liposuction and tummy tucks, and non-surgical treatments, like CoolSculpting and laser therapy. The growing global demand for body contouring is fueled by increasing obesity rates, a rising aesthetic consciousness, and technological advancements in non-invasive procedures. Key applications include fat reduction, cellulite treatment, skin tightening, and skin rejuvenation, catering to clients in clinics, hospitals, and spas. As people increasingly prioritize their appearance alongside health, the body contouring market faces expansive growth opportunities. Significant drivers include improved safety profiles, minimal recovery time, and the increasing acceptance of aesthetic procedures across genders and age groups. However, challenges persist: high procedure costs, stringent regulatory compliance, and potential side effects from surgical interventions can inhibit market growth. Moreover, inconsistent economic conditions might impact individuals' discretionary spending on cosmetic procedures. Despite these hurdles, the market holds potential in regions like Asia-Pacific and Latin America due to burgeoning middle-class populations and increased disposable incomes. Businesses should capitalize on these opportunities by expanding service offerings and investing in advanced technologies like cryolipolysis and radiofrequency devices. For innovation, focusing on customizable treatments and integrating AI and machine learning to enhance procedural outcomes can differentiate market players. Research into pain-free, efficient, and economical procedures is another promising area. The nature of the body contouring market is dynamic and fiercely competitive, with continuous innovations driving market development. Businesses should maintain a keen understanding of consumer trends, leverage digital marketing, and establish strong customer education channels to maintain and expand their market share adeptly.

KEY MARKET STATISTICS
Base Year [2023] USD 354.37 million
Estimated Year [2024] USD 387.48 million
Forecast Year [2030] USD 765.34 million
CAGR (%) 11.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Body Contouring Market

The Body Contouring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expanding medical tourism industry driving demand for affordable body contouring services
    • Higher incidence of obesity and related conditions leading to increased interest in body contouring
    • Influence of social media and celebrity endorsements promoting body contouring treatments
    • Development of innovative body contouring treatments with minimal downtime ensuring quick recovery
  • Market Restraints
    • Limited awareness and knowledge about body contouring procedures among potential patients
    • Potential health risks associated with body contouring procedures affecting patient confidence
  • Market Opportunities
    • Emerging market for body contouring procedures in developing countries due to higher adoption rates
    • Strategic partnerships and acquisitions among key players leading to enhanced market share and growth
    • Rising awareness and acceptance of body contouring procedures among men creating new market segments
  • Market Challenges
    • Rising competition from non-invasive fat reduction treatments like cryolipolysis, ultrasound, and laser therapy impacting market share
    • High treatment costs and lack of insurance coverage discouraging patients from opting for body contouring procedures

Porter's Five Forces: A Strategic Tool for Navigating the Body Contouring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Body Contouring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Body Contouring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Body Contouring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Body Contouring Market

A detailed market share analysis in the Body Contouring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Body Contouring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Body Contouring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Body Contouring Market

A strategic analysis of the Body Contouring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Body Contouring Market, highlighting leading vendors and their innovative profiles. These include Aerolase, Allergan, Alma Lasers, BTL Aesthetics, Cutera, Cynosure, EndyMed, Fotona, Galderma, Hologic, InMode, Lumenis, Merz Pharma, Sciton, Solta Medical, Syneron Medical, ThermiGen, Valeant Pharmaceuticals, Venus Concept, and Zimmer Aesthetics.

Market Segmentation & Coverage

This research report categorizes the Body Contouring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Invasive, Minimally Invasive, and Non-Invasive. The Invasive is further studied across Lower Body Lift, Traditional Liposuction, and Tummy Tuck. The Minimally Invasive is further studied across Laser-Assisted Liposuction and Radiofrequency-Assisted Liposuction. The Non-Invasive is further studied across Cryolipolysis, High-Intensity Focused Ultrasound (HIFU), Laser Lipolysis, and Radiofrequency.
  • Based on Technology, market is studied across Cryolipolysis, Injectables, Laser, Radiofrequency, and Ultrasound.
  • Based on End-User, market is studied across Hospitals, Medical Spas, and Specialty Clinics.
  • Based on Application, market is studied across Abdomen, Arms, Body & Back, Buttocks, and Thighs.
  • Based on Product Type, market is studied across Consumables and Devices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding medical tourism industry driving demand for affordable body contouring services
      • 5.1.1.2. Higher incidence of obesity and related conditions leading to increased interest in body contouring
      • 5.1.1.3. Influence of social media and celebrity endorsements promoting body contouring treatments
      • 5.1.1.4. Development of innovative body contouring treatments with minimal downtime ensuring quick recovery
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and knowledge about body contouring procedures among potential patients
      • 5.1.2.2. Potential health risks associated with body contouring procedures affecting patient confidence
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging market for body contouring procedures in developing countries due to higher adoption rates
      • 5.1.3.2. Strategic partnerships and acquisitions among key players leading to enhanced market share and growth
      • 5.1.3.3. Rising awareness and acceptance of body contouring procedures among men creating new market segments
    • 5.1.4. Challenges
      • 5.1.4.1. Rising competition from non-invasive fat reduction treatments like cryolipolysis, ultrasound, and laser therapy impacting market share
      • 5.1.4.2. High treatment costs and lack of insurance coverage discouraging patients from opting for body contouring procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Body Contouring Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Invasive
    • 6.2.1. Lower Body Lift
    • 6.2.2. Traditional Liposuction
    • 6.2.3. Tummy Tuck
  • 6.3. Minimally Invasive
    • 6.3.1. Laser-Assisted Liposuction
    • 6.3.2. Radiofrequency-Assisted Liposuction
  • 6.4. Non-Invasive
    • 6.4.1. Cryolipolysis
    • 6.4.2. High-Intensity Focused Ultrasound (HIFU)
    • 6.4.3. Laser Lipolysis
    • 6.4.4. Radiofrequency

7. Body Contouring Market, by Technology

  • 7.1. Introduction
  • 7.2. Cryolipolysis
  • 7.3. Injectables
  • 7.4. Laser
  • 7.5. Radiofrequency
  • 7.6. Ultrasound

8. Body Contouring Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Medical Spas
  • 8.4. Specialty Clinics

9. Body Contouring Market, by Application

  • 9.1. Introduction
  • 9.2. Abdomen
  • 9.3. Arms
  • 9.4. Body & Back
  • 9.5. Buttocks
  • 9.6. Thighs

10. Body Contouring Market, by Product Type

  • 10.1. Introduction
  • 10.2. Consumables
  • 10.3. Devices

11. Americas Body Contouring Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Body Contouring Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Body Contouring Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aerolase
  • 2. Allergan
  • 3. Alma Lasers
  • 4. BTL Aesthetics
  • 5. Cutera
  • 6. Cynosure
  • 7. EndyMed
  • 8. Fotona
  • 9. Galderma
  • 10. Hologic
  • 11. InMode
  • 12. Lumenis
  • 13. Merz Pharma
  • 14. Sciton
  • 15. Solta Medical
  • 16. Syneron Medical
  • 17. ThermiGen
  • 18. Valeant Pharmaceuticals
  • 19. Venus Concept
  • 20. Zimmer Aesthetics

LIST OF FIGURES

  • FIGURE 1. BODY CONTOURING MARKET RESEARCH PROCESS
  • FIGURE 2. BODY CONTOURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BODY CONTOURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BODY CONTOURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BODY CONTOURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BODY CONTOURING MARKET DYNAMICS
  • TABLE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY LOWER BODY LIFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY TRADITIONAL LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY TUMMY TUCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER-ASSISTED LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY-ASSISTED LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER LIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BODY CONTOURING MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BODY CONTOURING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BODY CONTOURING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BODY CONTOURING MARKET SIZE, BY ARMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BODY CONTOURING MARKET SIZE, BY BODY & BACK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BODY CONTOURING MARKET SIZE, BY BUTTOCKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGHS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BODY CONTOURING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BODY CONTOURING MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 355. TURKEY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 356. TURKEY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 357. TURKEY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY APPLICATION